Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancer
CONCLUSIONS: We report real-world outcomes from a large cohort of muscle-invasive bladder cancer patients undergoing surgical treatment with/out perioperative chemotherapy. Pathologic response rates to pre-surgical chemotherapy were modest and led to clinical benefit only in cT2 patients. Adjuvant chemotherapy provided survival benefit for pathologically advanced MIBC patients irrespective of pT/N staging.PMID:37880002 | DOI:10.1016/j.urolonc.2023.09.017
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Roger Li Shreyas Naidu Wenyi Fan Kyle Rose Heather Huelster George Daniel Grass Aram Vosoughi Jasreman Dhillon Youngchul Kim Shilpa Gupta Rohit K Jain Jingsong Zhang Logan Zemp Alice Yu Michael A Poch Philippe E Spiess Julio Pow-Sang Scott M Gilbert Wade Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Statistics | Study | Urology & Nephrology